0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > Recombinant Protein > Human Cell Expressed > SerpinA5 / PROCI Protein (His Tag)

SerpinA5 / PROCI Protein (His Tag) PDF Download

Catalog Size (Price) Quantity In Stock Operation Other Information
10309-H08H
  NO          

Serpin Peptidase Inhibitor Clade A Member 5 / SerpinA5 Protein

 

SerpinA5 / PROCI Protein Price Inquiry ( Available Sizes )

SerpinA5 / PROCI Protein Product Information

SerpinA5 Synonym: PAI3, PCI, PLANH3, PROCI
Protein Construction: A DNA sequence encoding the human SerpinA5 precursor ( NP_000615.3 ) ( Met 1 - Pro 406 ) was expressed with a C-terminal polyhistidine tag.
Source: Human
Expression Host: Human Cells

SerpinA5 / PROCI Protein QC Testing

Purity: > 97% as determined by SDS-PAGE. SDS-PAGE:
SerpinA5 protein

SerpinA5 protein

Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
Stability: Samples are stable for up to twelve months from date of receipt at -70℃
Predicted N terminal: His 20
Molecular Mass: The recombinant human SerpinA5 consists of 398amino acids and predicts amolecular mass of 45 kDa. By SDS-PAGE, the apparent molecular mass of rhSerpinA5 is approximately 50-55 kDa due to the glycosylation.
Formulation: Lyophilized from sterile PBS, pH 7.2
  1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
  2. Please contact us for any concerns or special requirements.

SerpinA5 / PROCI Protein Usage Guide

Storage: Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution: A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

Serpin A5 / PROCI Protein Related Products & Topics

Related Areas:

Enzyme>>Protease & Regulator>>Serine Protease & Regulator>>Serpin Superfamily>>Protein C Inhibitor/SerpinA5

Immunology>>Innate Immunity>>Coagulation>>Protein C Inhibitor/SerpinA5

Proteins:

Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No Size/Price
Protein C Inhibitor/SerpinA5 Human Protein C Inhibitor/SerpinA5 Protein, Recombinant 10309-H08H 20µg($290) ; Order

Antibodies:

Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No Size/Price
Human Protein C Inhibitor/SerpinA5 WB, ELISA Mouse Monoclonal Antibody 10309-MM01 ; Order
Human Protein C Inhibitor/SerpinA5 WB, ELISA Rabbit Polyclonal Antibody 10309-RP02 ; Order
Human Protein C Inhibitor/SerpinA5 WB, ELISA Rabbit Polyclonal Antibody (Antigen Affinity Purified) 10309-RP03 Order

SerpinA5 / PROCI Protein Description

Serpin A5, also well known as protein C inhibitor (PCI), is a member of the human serpin superfamily consists of at least 35 members. It is synthesized in the liver and has been detected in saliva, cerebral spinal fluid, amniotic fluid, tears and semen. As a potent inhibitor of the protein C anticoagulant pathway at the levels of both zymogen activation and enzyme inhibition, serpinA5 additionally inhibits a variety of serine protease including thrombin, factor Xa, several kallekreins and acrosin, and plays a role in the processes of blood coagulation and fertilization. Serpin A5 also inhibits urinary plasminogen activator (uPA), a mediator of tumor cell invasion, and regulates tumor growth and metastasis by inhibiting angiogenesis. Furthermore, recent studies have identified PCI as a potent and direct inhibitor of activated HGFA (hepatocyte growth factor activator), suggesting a novel function in the regulation of tissue repair and regeneration. Similar to serpins C1 and D1, the thrombin inhibitory activity of serpinA5 is enhanced by heparin.

References

  1. Alireza, R. et al., 1995, J. Biol. Chem. 270: 25336-25339.
  2. Silverman, G.A. et al., 2001, J. Biol. Chem. 276: 33293-33296.
  3. Malleier, J.M. et al., 2007, Blood. 109: 4769-4776.
  4. Asanuma, K. et al., 2007, Int. J. Cancer. 121: 955-965.
  5. Hayashi, T. et al., 2007, J. Thromb. Haemost. 5: 1477-1485.